{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:26:07Z","timestamp":1764433567362,"version":"3.44.0"},"reference-count":12,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,9,18]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>A female in her 60s was admitted via the emergency department following a respiratory collapse at home. She was profoundly hypoxic and hypertensive. For 1\u2009week prior, she had been self-administering subcutaneous (SC) low molecular weight heparin (LMWH) for a small postoperative pulmonary embolism (PE) and reported worsening, self-resolving episodes of breathlessness 1 hour post-injection. Repeat imaging revealed a new small PE and blood tests showed a significant platelet drop. Her heparin-induced thrombocytopaenia (HIT) antibody test was positive. A diagnosis of HIT-associated anaphylactoid reaction was made. She was switched to a direct oral anticoagulant and fully recovered. This condition is well described, often presenting with profound respiratory compromise that can be misdiagnosed as \u2018massive PE\u2019. A key differentiation is that there is often hypertension instead of hypotension. This case, however, is unusual as it was triggered by SC LMWH not intravenous heparin as previously described in the literature.<\/jats:p>","DOI":"10.1136\/bcr-2024-262825","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T01:35:30Z","timestamp":1729820130000},"page":"e262825","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Mimic of massive pulmonary embolism: heparin-induced thrombocytopaenia (HIT)-associated anaphylactoid reactions following subcutaneous low molecular weight heparin"],"prefix":"10.1136","volume":"17","author":[{"given":"Natalie","family":"McGahan","sequence":"first","affiliation":[{"name":"Acute Medicine, University Hospitals Sussex NHS Foundation Trust, Chichester, West Sussex, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Ziller","sequence":"additional","affiliation":[{"name":"Acute Medicine, University Hospitals Sussex NHS Foundation Trust, Chichester, West Sussex, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Phipps","sequence":"additional","affiliation":[{"name":"Acute Medicine, University Hospitals Sussex NHS Foundation Trust, Chichester, West Sussex, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"2025082709321070000_17.10.e262825.1","unstructured":"National Institute for Health and Care Excellence . Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. NICE Guideline No. 89; 2018. Available: https:\/\/www.nice.org.uk\/guidance\/ng89\/"},{"key":"2025082709321070000_17.10.e262825.2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bjh.12059","article-title":"Guidelines on the diagnosis and management of heparin\u2010induced thrombocytopenia: second edition","volume":"159","author":"Watson","year":"2012","journal-title":"Br J Haematol"},{"key":"2025082709321070000_17.10.e262825.3","doi-asserted-by":"publisher","DOI":"10.1517\/14740330902778180"},{"key":"2025082709321070000_17.10.e262825.4","unstructured":"Hoffbrand AV , Chowdary P , Collins G , et al . Hoffbrand\u2019s Essential Haematology. Hoboken, NJ: Wiley-Blackwell, 2024."},{"key":"2025082709321070000_17.10.e262825.5","first-page":"763","article-title":"The heparin-induced thrombocytopaenia syndrome: An update","volume":"102","author":"Laster","year":"1987","journal-title":"Cent Surg Assoc"},{"key":"2025082709321070000_17.10.e262825.6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5414\/CNP63236","article-title":"Thrombocytopenia and anaphylaxis secondary to heparin in a hemodialysis patient","volume":"63","author":"Alonso","year":"2005","journal-title":"CN"},{"key":"2025082709321070000_17.10.e262825.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(98)70146-6"},{"key":"2025082709321070000_17.10.e262825.8","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315445"},{"key":"2025082709321070000_17.10.e262825.9","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/14.2.121"},{"key":"2025082709321070000_17.10.e262825.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2004.00224.x"},{"key":"2025082709321070000_17.10.e262825.11","doi-asserted-by":"crossref","unstructured":"Jayarangaiah A , Epperla N . Early recognition is the key to success: pulseless electrical activity (PEA) as a manifestation of heparin-induced anaphylactoid reaction. BMJ Case Rep 2015. doi:10.1136\/bcr-2015-210828","DOI":"10.1136\/bcr-2015-210828"},{"key":"2025082709321070000_17.10.e262825.12","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.16.1511.33688"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-262825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:32:21Z","timestamp":1756312341000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-262825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":12,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,24]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1136\/bcr-2024-262825"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-262825","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}